SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-012808
Filing Date
2018-02-27
Accepted
2018-02-27 16:25:22
Documents
11
Period of Report
2018-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-7075_18k.htm 8-K 27098
2 EX-99.1 a18-7075_1ex99d1.htm EX-99.1 154091
3 EX-99.2 a18-7075_1ex99d2.htm EX-99.2 13992
4 GRAPHIC g70751mm01i001.gif GRAPHIC 4843
5 GRAPHIC g70751moi001.gif GRAPHIC 34428
6 GRAPHIC g70751moi002.gif GRAPHIC 129517
7 GRAPHIC g70751moi003.gif GRAPHIC 101183
8 GRAPHIC g70751moi004.gif GRAPHIC 80447
9 GRAPHIC g70751moi005.gif GRAPHIC 87565
10 GRAPHIC g70751moi006.gif GRAPHIC 68352
11 GRAPHIC g70751moi007.gif GRAPHIC 100528
  Complete submission text file 0001104659-18-012808.txt   1032401
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 18645427
SIC: 2834 Pharmaceutical Preparations